Antioxidant treatment and TNF-α knockdown attenuate high glucose-induced sclerostin expression, suggesting that hyperglycemia induces high sclerostin expression via enhancing the production of reactive oxygen species and TNF-α. The gene discussed is SOST; the disease is Hyperglycemia.